Steuber T - Search Results

1

A nuclear shift of GSK3β protein is an independent prognostic factor in prostate cancer.

Eichenauer T, Hussein M, Hube-Magg C, Kluth M, Büscheck F, Höflmayer D, Tsourlakis MC, Steurer S, Clauditz TS, Luebke AM, Burandt E, Wilczak W, Hinsch A, Dum D, Beyer B, Steuber T, Huland H, Graefen M, Simon R, Sauter G, Melling N, Schlomm T, Minner S. Eichenauer T, et al. Among authors: steuber t. Oncotarget. 2019 Mar 1;10(18):1729-1744. doi: 10.18632/oncotarget.26739. eCollection 2019 Mar 1. Oncotarget. 2019. PMID: 30899444 Free PMC article.

2

[Chemoprevention of prostatic carcinoma].

Hammerer P, Graefen M, Steuber T, Huland H. Hammerer P, et al. Among authors: steuber t. Urologe A. 2000 Jul;39(4):304-8. doi: 10.1007/s001200050361. Urologe A. 2000. PMID: 10957770 Review. German.

3

Human glandular kallikrein 2 levels in serum for discrimination of pathologically organ-confined from locally-advanced prostate cancer in total PSA-levels below 10 ng/ml.

Haese A, Graefen M, Steuber T, Becker C, Pettersson K, Piironen T, Noldus J, Huland H, Lilja H. Haese A, et al. Among authors: steuber t. Prostate. 2001 Oct 1;49(2):101-9. doi: 10.1002/pros.1123. Prostate. 2001. PMID: 11582588

4

Discrimination of benign from malignant prostatic disease by selective measurements of single chain, intact free prostate specific antigen.

Steuber T, Nurmikko P, Haese A, Pettersson K, Graefen M, Hammerer P, Huland H, Lilja H. Steuber T, et al. J Urol. 2002 Nov;168(5):1917-22. doi: 10.1016/S0022-5347(05)64263-2. J Urol. 2002. PMID: 12394676

5

Total and Gleason grade 4/5 cancer volumes are major contributors of human kallikrein 2, whereas free prostate specific antigen is largely contributed by benign gland volume in serum from patients with prostate cancer or benign prostatic biopsies.

Haese A, Graefen M, Steuber T, Becker C, Noldus J, Erbersdobler A, Huland E, Huland H, Lilja H. Haese A, et al. Among authors: steuber t. J Urol. 2003 Dec;170(6 Pt 1):2269-73. doi: 10.1097/01.ju.0000095794.04551.0c. J Urol. 2003. PMID: 14634394

6

[Isoforms of free prostate-specific antigen].

Haese A, Noldus J, Steuber T, Huland H, Lilja H. Haese A, et al. Among authors: steuber t. Urologe A. 2004 Jun;43(6):675-9. doi: 10.1007/s00120-004-0584-8. Urologe A. 2004. PMID: 15221148 Review. German.

7

Association of free-prostate specific antigen subfractions and human glandular kallikrein 2 with volume of benign and malignant prostatic tissue.

Steuber T, Niemela P, Haese A, Pettersson K, Erbersdobler A, Felix Chun KH, Graefen M, Kattan MW, Huland H, Lilja H. Steuber T, et al. Prostate. 2005 Apr 1;63(1):13-8. doi: 10.1002/pros.20156. Prostate. 2005. PMID: 15378521

8

Extracorporeal shockwave lithotripsy compared with ureteroscopy for the removal of small distal ureteral stones.

Hautmann S, Friedrich MG, Fernandez S, Steuber T, Hammerer P, Braun PM, Jünemann KP, Huland H. Hautmann S, et al. Among authors: steuber t. Urol Int. 2004;73(3):238-43. doi: 10.1159/000080834. Urol Int. 2004. PMID: 15539843

9

Transition zone cancers undermine the predictive accuracy of Partin table stage predictions.

Steuber T, Karakiewicz PI, Augustin H, Erbersdobler A, Lange I, Haese A, Chun KH, Walz J, Graefen M, Huland H. Steuber T, et al. J Urol. 2005 Mar;173(3):737-41. doi: 10.1097/01.ju.0000152591.33259.f9. J Urol. 2005. PMID: 15711259

10

Surgical management of prostate cancer: advances based on a rational approach to the data.

Meraney AM, Haese A, Palisaar J, Graefen M, Steuber T, Huland H, Klein EA. Meraney AM, et al. Among authors: steuber t. Eur J Cancer. 2005 Apr;41(6):888-907. doi: 10.1016/j.ejca.2005.02.005. Eur J Cancer. 2005. PMID: 15808956 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

247 results

Search Page